alamethicin and Leukemia--Lymphoid

alamethicin has been researched along with Leukemia--Lymphoid* in 1 studies

Other Studies

1 other study(ies) available for alamethicin and Leukemia--Lymphoid

ArticleYear
Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: inhibition by taxol and membrane permeabilising agents.
    Biochemistry and molecular biology international, 1993, Volume: 30, Issue:4

    Inside-out membrane vesicles prepared from multidrug resistant human leukemic cells (CEM/VBL1000), but not from sensitive cells, transported [3H]-labelled vinblastine (VBL) in an ATP-dependent manner, reaching a plateau level by 15 min. The transport occurred with an apparent Km of 60 +/- 20nM. Verapamil (10 microM), and taxol (IC50 = 1 microM) prevented VBL uptake and evoked VBL diffusion from vesicles when added after VBL uptake had reached steady state. The channel forming agent alamethicin prevented net uptake of VBL and addition of alamethicin to the vesicles after the steady-state had been reached resulted in the rapid efflux of [3H]VBL. Very low concentrations of Triton X-100 (0.01 % v/v) also prevented net uptake of VBL, whilst addition of Triton X-100 and making the medium hypo-osmotic after the steady state had been reached caused the [3H]VBL to rapidly diffuse out of the vesicles. These observations indicate that VBL is actively transported into the lumen of inside-out vesicles from multidrug resistant leukaemia cells.

    Topics: Alamethicin; Cell Membrane; Cell Membrane Permeability; Drug Resistance; Humans; Leukemia, Lymphoid; Octoxynol; Osmolar Concentration; Paclitaxel; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured; Verapamil; Vinblastine

1993